0001181431-11-050247.txt : 20110922
0001181431-11-050247.hdr.sgml : 20110922
20110922171541
ACCESSION NUMBER: 0001181431-11-050247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110920
FILED AS OF DATE: 20110922
DATE AS OF CHANGE: 20110922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ehrlich Christopher B
CENTRAL INDEX KEY: 0001293973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51967
FILM NUMBER: 111103695
MAIL ADDRESS:
STREET 1: C/O INTERWEST PARTNERS
STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: (510) 215-3500
MAIL ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
rrd322433.xml
INTERWEST/ EHRLICH PURCHASE
X0304
4
2011-09-20
0
0001178711
Transcept Pharmaceuticals Inc
TSPT
0001293973
Ehrlich Christopher B
C/O TRANSCEPT PHARMACEUTICALS, INC.
1003 W. CUTTING BLVD, SUITE 110
POINT RICHMOND
CA
94804
1
0
1
0
Common Stock
2011-09-20
4
P
0
514848
6.585
A
1766656
I
See footnote
Common Stock
2011-09-21
4
P
0
217228
7.2418
A
1983884
I
See footnote
The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $5.64 to $7.00 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The reported securities are owned directly by InterWest Partners IX, L.P. ("the LP") and may be deemed to be beneficially owned indirectly by InterWest Management Partners IX, LLC ("the LLC"), as general partner of the LP. The reporting person as a venture member of the LLC disclaims any beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $6.96 to $7.50 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
/s/ Marilyn E. Wortzman, by power of attorney
2011-09-22